Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity
- PMID: 28220780
- DOI: 10.1038/ajg.2017.19
Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity
Abstract
Objectives: We assessed the prognostic significance of infections in relation to current prognostic scores and explored if infection could be considered per se a distinct clinical stage in the natural history of cirrhosis.
Methods: We included consecutive patients with cirrhosis admitted to a tertiary referral liver unit for at least 48 h over a 2-year period. Diagnosis of infection was based on positive cultures or strict established criteria. We used competing risk analysis and propensity score matching for data analysis.
Results: 501 patients (63% male, 48% alcoholic liver disease, median Model of End-stage Liver Disease (MELD)=17) underwent 781 admissions over the study period. Portal hypertensive bleeding and complicated ascites were the commonest reasons of admission. The incidence of proven bacterial infection was 25.6% (60% community acquired and 40% nosocomial). Survival rates at 3, 6, 12, and 30 months were 83%, 77%, 71%, and 62% in patients without diagnosis of infection, vs. 50%, 46%, 41%, and 34% in patients with diagnosis of infection. Overall survival was independently associated with MELD score (hazards ratio (HR) 1.099), intensive care (ITU) stay (HR 1.967) and bacterial infection (HR 2.226). Bacterial infection was an independent predictor of survival even when patients who died within the first 30 days were excluded from the analysis in Cox regression (HR 2.013) and competing risk Cox models in all patients (HR 1.46) and propensity risk score-matched infected and non-infected patients (HR 1.67).
Conclusions: Infection most likely represents a distinct prognostic stage of cirrhosis, which affects survival irrespective of disease severity, even after recovery from the infective episode.
Similar articles
-
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.Gastroenterology. 2007 Aug;133(2):481-8. doi: 10.1053/j.gastro.2007.05.024. Epub 2007 May 21. Gastroenterology. 2007. PMID: 17681169 Clinical Trial.
-
Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.Dig Dis Sci. 2017 Feb;62(2):534-542. doi: 10.1007/s10620-016-4185-3. Epub 2016 May 6. Dig Dis Sci. 2017. PMID: 27154510
-
Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.Dig Dis Sci. 2016 Nov;61(11):3335-3345. doi: 10.1007/s10620-016-4261-8. Epub 2016 Aug 1. Dig Dis Sci. 2016. PMID: 27480088
-
New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.Hepatol Int. 2018 Feb;12(Suppl 1):34-43. doi: 10.1007/s12072-017-9808-z. Epub 2017 Jul 5. Hepatol Int. 2018. PMID: 28681347 Review.
-
[Complications of liver cirrhosis: portal hypertension, gastroesophageal varices and ascites].Praxis (Bern 1994). 2003 Aug 27;92(35):1427-34. doi: 10.1024/0369-8394.92.35.1427. Praxis (Bern 1994). 2003. PMID: 14526628 Review. German.
Cited by
-
Current Concepts on Bacterial and Fungal Infections in Cirrhosis.Clin Liver Dis (Hoboken). 2019 Oct 9;14(3):87-91. doi: 10.1002/cld.799. eCollection 2019 Sep. Clin Liver Dis (Hoboken). 2019. PMID: 31632656 Free PMC article. Review. No abstract available.
-
Nosocomial infections in female compared with male patients with decompensated liver cirrhosis.Sci Rep. 2022 Feb 28;12(1):3285. doi: 10.1038/s41598-022-07084-9. Sci Rep. 2022. PMID: 35228572 Free PMC article.
-
Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: single center experience in Serbia.BMC Infect Dis. 2019 Feb 12;19(1):141. doi: 10.1186/s12879-019-3761-5. BMC Infect Dis. 2019. PMID: 30755176 Free PMC article.
-
Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.World J Hepatol. 2018 Feb 27;10(2):254-266. doi: 10.4254/wjh.v10.i2.254. World J Hepatol. 2018. PMID: 29527261 Free PMC article. Review.
-
The Usefulness of Mayo End-stage Liver Disease (MELD) and MELD-Sodium (MELD-Na) Scores for Predicting Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis.Cureus. 2023 Apr 30;15(4):e38343. doi: 10.7759/cureus.38343. eCollection 2023 Apr. Cureus. 2023. PMID: 37143642 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical